Study unlocks the mystery of neonatal neutropenia in newborns

Compared to adults, newborns are highly susceptible to infections and these infections can cause serious health complications and even death.

Frontline Combo Yields High Remission Rate in Hairy Cell Leukemia

Use of the BRAF inhibitor vemurafenib (Zelboraf) combined with the anti-CD20 monoclonal antibody obinutuzumab (Gazyva) led to high rates of complete remission as frontline therapy

September 26, 2023

With TV drug ads, what you see is not necessarily what you get

Triumphant music plays as cancer patients go camping, do some gardening, and watch fireworks in ads for Opdivo+Yervoy, a combination of immunotherapies to treat metastatic melanoma

September 9, 2024

US aid freeze puts HIV treatment in Africa at risk

Milicent Muyoma has been turned away twice from the clinic where she collects her HIV medication in Mathare, an informal settlement in Nairobi, Kenya.

February 6, 2025

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.